In particular, it has been reported that HIPK2 loss-of-heterozygosity occurs frequently in radiation-induced mouse lymphomas and in human thyroid carcinomas, indicating that loss of a single allele is sufficient to impact tumor susceptibility, at least in some contexts [5, 40]. Here, HIPK2 is linked to lymphoma.